
Pharma
Abcam Expands Genedata Partnership To Accelerate AI-Driven Antibody Development
Abcam has deployed Genedata Biologics across key R&D sites to unify antibody data and support faster AI-enabled development.
PharmaCompany
Abcam has expanded its partnership with Genedata by deploying Genedata Biologics at key R&D sites. This initiative aims to unify antibody data and enhance the speed of AI-driven antibody development.
+0 in the last 30 days
1 live
Latest tracker entry
live500 new antibodies developed
Built on Genedata




MachineCon USA · from AIM Media House
An invitation-led day for the CIOs, CDOs and Chief AI Officers who own enterprise AI strategy.



